Company profile
Hybrisan | Innovators in Infection Control
Hybrisan is a MedTech company founded to revolutionise wound care through the development of our unique WoundSan technology.
Updated 06 Jun 2026 16:52
Reference milestones and recent Companies House filing stream events.
Next accounts due date
Next confirmation statement due date
AA01 | Transaction MzUyNzM3MTc0OGFkaXF6a2N4
Published 19 Jun 2026 16:03
Last accounts made up date
Last confirmation statement made up date
MR01 | Transaction MzQzNjQwOTgxNGFkaXF6a2N4
Published 25 Sep 2024 12:01
MR01 | Transaction MzQzNjQwODk3OGFkaXF6a2N4
Published 25 Sep 2024 11:32
CS01 | Transaction MzQzNDY1MDgyNGFkaXF6a2N4
Published 05 Sep 2024 14:22
MR01 | Transaction MzQzNDE4MDM5NGFkaXF6a2N4
Published 05 Sep 2024 13:23
Company registered at Companies House
1 Oct 2022 to 30 Sep 2023
There is an urgent need for innovate products in the chronic wound care market due to an increasing prevalence of chronic wounds and a lack of confidence in existing technologies. There were an estimated 3.8 million patients with a wound managed by the NHS in 2017/18 with an increase in prevalence of 71% between 2012/13 and 2017/18\. There are several ant...
1 Jun 2020 to 30 Nov 2020
Covid-19 has created a shortage of anti-viral products such as sanitisers and Personal Protective Equipment (PPE). This is both a short-term issue -- to cope with a huge increase in demand -- and a long-term issue as the crisis has exposed the fragility of international supply chains. Hybrisan has developed a biocidal electrospun nonwoven material than ca...
